Delivery Order SPE2DB22D2211-SPE2DB25FSBMG
- Not listed
- The Defense Logistics Agency awarded a $55,988.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Wezlana 90 mg/mL syringes. The contract is non-competitive with no set-aside designation and carries an ultimate completion date of July 17, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantially...
- The Defense Logistics Agency awarded a delivery order valued at $6,289.42 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $5,568.57 delivery order for Wezlana 90 mg/ml syringes, with an ultimate completion date of September 19, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract awarded under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes with a ceiling value of $13,396.25 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and the work will be performed in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.91 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the place of performance in Conshohocken, PA. This delivery order represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,754.18 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $12,161.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for WEZLANA 90 mg/mL syringes on July 18, 2025, with completion targeted for July 21, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor will perform work at its corporate...
- The Defense Logistics Agency awarded a $16,577.11 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Wezlana 90 mg/mL syringes. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 14, 2025, and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $33,849.19 delivery order for Wezlana 90 mg/ml syringes, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10,048.89 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Wezlana 90 mg/ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBMGDelivery Order
The Defense Logistics Agency awarded a $17,011.92 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price contract, with an ultimate completion date of July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. The SPE2DX IDV functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, medical devices, and specialized commodities across multiple therapeutic domains. This delivery order exemplifies the company's role in fulfilling the Defense Health Agency's medical supply requirements through flexible and competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 7/24/25 |